Sodium valproate and valproic acid appear to lessen barbiturate metabolism; hence, barbiturate blood concentrations must be monitored and acceptable dosage adjustments designed as indicated.Pentobarbital features in the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This action potentiates GABA outcomes, resulting in CNS depr